ResoClip is an innovative, fully biodegradable marker clip designed to support accurate localization of targeted sites during diagnostic and interventional procedures.
It provides a biocompatible and sustainable alternative to traditional metallic markers, maintaining excellent imaging visibility while naturally resorbing over time.
🧬 Multi-tissue applicability: Suitable for breast, colorectal, and other soft-tissue localization.
🩻 Imaging performance: Clearly visible under mammography, ultrasound, CT, and MRI.
🧪 Material safety: Composed of FDA-approved, biocompatible components ensuring patient safety.
🔷 Configurable geometry: Available in multiple shapes for procedural flexibility and precision.
ResoClip Ltd. is advancing the next generation of biodegradable medical devices. Our technology is based on implantable devices engineered from a proprietary polymer blend, designed to deliver both clinical precision and patient comfort.
By enabling devices to biodegrade naturally within the body, ResoClip’s approach eliminates the need for secondary removal procedures, thereby reducing patient discomfort, shortening recovery time, and improving overall treatment efficiency.
ResoClip Ltd. was founded by a team combining serial entrepreneurship, scientific innovation, and clinical excellence. Together, they bridge decades of experience across biomedical R&D, clinical practice, and global business leadership.
World-class expert in biodegradable polymers and drug delivery systems
With many years of R&D experience in both academia and industry, Prof. Domb has founded 15 biomed companies and introduced 10 biomedical products, including Gliadel, InSpace, Bioprotect, Deximun, Maze Water Filter (acquired by Strauss Water), Skeddedle, Canker Cover, Oramoist, NoBio, and Superfloc.
📧 Email: Avid@ekmd.huji.ac.il
🔗 LinkedIn: linkedin.com/in/avi-domb-a9650ab
Co-Founder & Medical Director
A global leader in breast cancer detection, Prof. Rachel Brem has dedicated her career to advancing early diagnosis and saving lives.
As Professor and Director of Breast Imaging and Intervention at The George Washington University and Co-Founder of The Brem Foundation, she is committed to expanding access to breast cancer screening for all women.
